Satakarni Makkapati News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aurobindo Pharma arm gets CDSCO panel nod to market biosimilar of cancer drug

Aurobindo Pharma arm gets CDSCO panel nod to market biosimilar of cancer drug
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

Aurobindo pharmaSatakarni makkapatiCurateq biologicsSubject experts committeeCentral drugs standard control organizationPeptides satakarni makkapati

Aurobindo Pharma s China plant gets EU s GMP approval - The Hindu BusinessLine

Aurobindo Pharma s China plant gets EU s GMP approval - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshSatakarni makkapatiSanthanam subramanianAurobindo pharmaAurobindo biosimilarsEuropean union good manufacturing practicesEuropean unionGood manufacturing practicesPeptide businesses

BioFactura and CuraTeQ Sign Exclusive License for BFI-751—A Biosimilar to Stelara

Frederick, Maryland (PRWEB) July 10, 2023 BioFactura, Inc. today announced that CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo

Andhra pradeshUnited kingdomCurateq biologicsNithyananda reddyDarryl sampeyStelara ustekinumabJeffreyn hausfeldAurobindo pharmaSatakarni makkapatiBiofactura incAurobindo pharma ltdCurateq biologics privateChief medical officerCurateq biologics private limitedAurobindo pharma limitedEmerging markets

Aurobindo Pharma arm to market biosimilar to treat Crohn s disease, arthritis

Under the terms, CuraTeQ has been granted exclusive license rights to commercialize BFI-751 in all major regulated markets including US, EU, UK, and Canada

United kingdomAndhra pradeshAurobindo pharmaStelara ustekinumabSatakarni makkapatiCurateq biologicsEmerging marketsKotak institutional equities

CuraTeQ obtains exclusive rights for BioFactura s Ustekinumab biosimilar

CuraTeQ obtains exclusive rights for BioFactura s Ustekinumab biosimilar
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomAndhra pradeshJeffreyn hausfeldDarryl sampeyBiofactura ustekinumabNithyananda reddyAurobindo pharmaStelara ustekinumabSatakarni makkapatiCurateq biologics privatePharma limitedCurateq biologics private limitedEmerging marketsVice chairmanChief medical officer